Saif-Ur-Rehman Muhammad, Shahnawaz-Ul-Rehman Muhammad, Khan Muhammad Sajjad
Durr-e-Samin, Ph.D Candidate. Centre of Agriculture Biochemistry and Biotechnology, University of Agriculture, Faisalabad, Pakistan.
Muhammad Saif-ur-Rehman, Ph.D. Institute of Animal and Dairy Sciences, University of Agriculture, Faisalabad, Pakistan.
Pak J Med Sci. 2018 Sep-Oct;34(5):1158-1163. doi: 10.12669/pjms.345.15764.
BACKGROUND & OBJECTIVE: Large spectrum of pathogenic mutations is known as a major cause of hereditary breast ovarian cancer in human all over the world. The objective of present study was to find out the association of mutations and at exon-2 with age of onset and family history of gynecological cancer among the selected cohort of breast cancer patients in Pakistani population and to provide guidelines for treatment strategies.
For the present study 115 subjects were recruited from different hospitals of Punjab, Pakistan, during May, 2017 to February, 2018. The inclusion criteria were age ≥30, without any previous testing and willingness to participate in present study. Subjects were interviewed for various demographic factors. Out of 115 subjects, 46 were selected on the basis of findings of previous studies and approximately 3 ml of blood was collected in EDTA coated vials for analysis of BRCA1 exon-2. Column based DNA extraction was performed by using commercial kit and exon specific primers were used to amplify exon 2 and PCR products were sent for sequencing to Eurofins Genomics. Sequences were analyzed through the BLAST program at National Center for Biotechnology Information (NCBI) and Bio Edit software. Accession numbers were obtained on submission of sequences in GenBank.
. None of the samples revealed positive results for .
mutation has association with early age onset of breast cancer. The direct sequencing is very useful approach for analysis and exon specific selected cohort from Pakistani population.
大量的致病突变是全世界人类遗传性乳腺癌和卵巢癌的主要原因。本研究的目的是在巴基斯坦人群中选定的乳腺癌患者队列中,找出外显子2突变与发病年龄及妇科癌症家族史之间的关联,并为治疗策略提供指导。
在2017年5月至2018年2月期间,从巴基斯坦旁遮普省的不同医院招募了115名受试者。纳入标准为年龄≥30岁,此前未进行过任何检测且愿意参与本研究。对受试者进行了各种人口统计学因素的访谈。在115名受试者中,根据先前研究的结果选择了46名,将约3毫升血液收集到乙二胺四乙酸(EDTA)包被的小瓶中,用于分析BRCA1外显子2。使用商业试剂盒进行基于柱的DNA提取,并使用外显子特异性引物扩增外显子2,PCR产物被送去欧洲基因库(Eurofins Genomics)进行测序。通过美国国立生物技术信息中心(NCBI)的BLAST程序和生物编辑软件对序列进行分析。在GenBank中提交序列后获得登录号。
所有样本均未显示出……的阳性结果。
……突变与乳腺癌的早发有关。直接测序是分析……以及从巴基斯坦人群中选择特定队列外显子的非常有用的方法。